These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36474449)

  • 21. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
    Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
    Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
    Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy and mechanism of loading dose clopidogrel in patients with transient ischemic attack and minor stroke].
    Yang L; Diao SS; Ding YP; Huang SJ; Sun T; Lu Y; Fang Q; Cai XY; Kong Y; Xu Z
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):349-353. PubMed ID: 30772975
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
    Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD
    JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Analysis of Usefulness of Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack.
    Medranda GA; Zhang C; Doros G; Yerasi C; Case BC; Weintraub WS; Waksman R
    Am J Cardiol; 2021 Aug; 153():129-134. PubMed ID: 34226040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of body weight on bleeding events of aspirin in ischemic stroke or transient ischemic attack patients.
    Wang X; Zhu Q; Wu Y; Li H; Deng X; Cheng J; Zhang Z; Ma Y; Shi T
    J Clin Pharm Ther; 2022 Oct; 47(10):1684-1689. PubMed ID: 35748660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial.
    Jeng JS; Sun Y; Lee JT; Lin RT; Chen CH; Po HL; Lin HJ; Liu CH; Sun MH; Sun MC; Chern CM; Lien LM; Chiu HC; Hu HH; Chiou HY; Chen ST; Ma H; Hsu CY;
    Int J Stroke; 2015 Jan; 10(1):123-7. PubMed ID: 25394855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors.
    Luengo-Fernandez R; Li L; Rothwell PM;
    Int J Stroke; 2021 Aug; 16(6):719-726. PubMed ID: 31564244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
    Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
    Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiaggregant treatment: present and future].
    Kase CS
    Rev Neurol; 1999 May 16-31; 28(10):1013-6. PubMed ID: 10416242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
    Li X; Zhou G; Zhou X; Zhou S
    J Neurol Sci; 2013 Sep; 332(1-2):92-6. PubMed ID: 23871093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function in stroke/transient ischemic attack patients treated with tocotrienol.
    Slivka A; Rink C; Paoletto D; Sen CK
    FASEB J; 2020 Sep; 34(9):11838-11843. PubMed ID: 32686874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2Y12 receptor inhibitor plus aspirin versus aspirin treated within 24 hours of acute noncardioembolic ischemic stroke or TIA: Meta-analysis.
    Huang WY; Ovbiagele B; Lee M
    J Formos Med Assoc; 2022 Jun; 121(6):1053-1061. PubMed ID: 34426033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early Secondary Prevention in Transient Ischemic Attack (TIA) and Minor Stroke.
    Tse D; Hill MD; Coutts SB
    Curr Neurol Neurosci Rep; 2019 May; 19(6):34. PubMed ID: 31089960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.